228 related articles for article (PubMed ID: 36118762)
1. The atherogenic index of plasma: A novel factor more closely related to non-alcoholic fatty liver disease than other lipid parameters in adults.
Liu J; Zhou L; An Y; Wang Y; Wang G
Front Nutr; 2022; 9():954219. PubMed ID: 36118762
[TBL] [Abstract][Full Text] [Related]
2. Can atherogenic indices and the triglyceride-glucose index be used to predict erectile dysfunction?
Sambel M; Erdogan A; Caglayan V; Avci S; Kilic S; Yildiz HE; Keskin E
Sex Med; 2023 Dec; 11(6):qfad069. PubMed ID: 38250336
[TBL] [Abstract][Full Text] [Related]
3. The value of the atherogenic index of plasma in non-obese people with non-alcoholic fatty liver disease: a secondary analysis based on a cross-sectional study.
Dong BY; Mao YQ; Li ZY; Yu FJ
Lipids Health Dis; 2020 Jun; 19(1):148. PubMed ID: 32576204
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.
Sheng G; Lu S; Xie Q; Peng N; Kuang M; Zou Y
Lipids Health Dis; 2021 Oct; 20(1):134. PubMed ID: 34629059
[TBL] [Abstract][Full Text] [Related]
5. Relationship Between Six Insulin Resistance Surrogates and Nonalcoholic Fatty Liver Disease Among Older Adults: A Cross-Sectional Study.
Li H; Shi Z; Chen X; Wang J; Ding J; Geng S; Sheng X; Shi S
Diabetes Metab Syndr Obes; 2023; 16():1685-1696. PubMed ID: 37309507
[TBL] [Abstract][Full Text] [Related]
6. Association between the atherogenic index of plasma and new-onset non-alcoholic fatty liver disease in non-obese participants.
Li K; Li J; Cheng X; Wang J; Li J
Front Endocrinol (Lausanne); 2022; 13():969783. PubMed ID: 36060971
[TBL] [Abstract][Full Text] [Related]
7. Triglyceride glucose index and Atherogenic index of plasma for predicting colorectal neoplasms in patients without cardiovascular diseases.
Han M; Wang H; Yang S; Zhu S; Zhao G; Shi H; Li P
Front Oncol; 2022; 12():1031259. PubMed ID: 36452491
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between triglyceride-glucose index and non-alcoholic fatty liver disease].
Liu YT; Wang W; Tong J; Wang BY
Zhonghua Gan Zang Bing Za Zhi; 2021 May; 29(5):451-455. PubMed ID: 34107583
[No Abstract] [Full Text] [Related]
9. Association between the ZJU index and risk of new-onset non-alcoholic fatty liver disease in non-obese participants: a Chinese longitudinal prospective cohort study.
Zheng K; Yin Y; Guo H; Ma L; Liu R; Zhao T; Wei Y; Zhao Z; Cheng W
Front Endocrinol (Lausanne); 2024; 15():1340644. PubMed ID: 38405152
[TBL] [Abstract][Full Text] [Related]
10. The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population.
Hu H; Han Y; Cao C; He Y
J Transl Med; 2022 Sep; 20(1):398. PubMed ID: 36064712
[TBL] [Abstract][Full Text] [Related]
11. Association between the Triglyceride-Glucose Index and Non-Alcoholic Fatty Liver Disease in patients with Atrial Fibrillation.
Li X; Zhan F; Peng T; Xia Z; Li J
Eur J Med Res; 2023 Sep; 28(1):355. PubMed ID: 37726807
[TBL] [Abstract][Full Text] [Related]
12. Comparison of atherogenic indices for predicting the risk of metabolic syndrome in Southwest Iran: results from the Hoveyzeh Cohort Study (HCS).
Babaahmadi-Rezaei H; Raeisizadeh M; Zarezade V; Noemani K; Mashkournia A; Ghaderi-Zefrehi H
Diabetol Metab Syndr; 2024 May; 16(1):112. PubMed ID: 38783371
[TBL] [Abstract][Full Text] [Related]
13. Triglyceride-Glucose Index is Significantly Associated with the Risk of Hyperuricemia in Patients with Nonalcoholic Fatty Liver Disease.
Qi J; Ren X; Hou Y; Zhang Y; Zhang Y; Tan E; Wang L
Diabetes Metab Syndr Obes; 2023; 16():1323-1334. PubMed ID: 37188227
[TBL] [Abstract][Full Text] [Related]
14. Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes.
Li N; Tan H; Xie A; Li C; Fu X; Xang W; Kirim A; Huang X
BMC Endocr Disord; 2022 Apr; 22(1):101. PubMed ID: 35428219
[TBL] [Abstract][Full Text] [Related]
15. Correlation between the triglyceride-glucose index and the onset of atrial fibrillation in patients with non-alcoholic fatty liver disease.
Zhang Y; Wang L; Qi J; Yu B; Zhao J; Pang L; Zhang W; Bin L
Diabetol Metab Syndr; 2023 May; 15(1):94. PubMed ID: 37158953
[TBL] [Abstract][Full Text] [Related]
16. The Metabolic Score for Insulin Resistance Index is Superior to the Triglyceride and Glucose Index in Identifying Nonalcoholic Fatty Liver Disease in Hyperuricemia Subjects.
Shu Y; Huang G; Mao Y
Diabetes Metab Syndr Obes; 2023; 16():4235-4246. PubMed ID: 38169634
[TBL] [Abstract][Full Text] [Related]
17. The predictive value of nontraditional lipid parameters for intracranial and extracranial atherosclerotic stenosis: a hospital-based observational study in China.
Yu S; Yan L; Yan J; Sun X; Fan M; Liu H; Li Y; Guo M
Lipids Health Dis; 2023 Jan; 22(1):16. PubMed ID: 36709301
[TBL] [Abstract][Full Text] [Related]
18. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
[No Abstract] [Full Text] [Related]
19. Utility of traditional and non-traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population.
Lu S; Kuang M; Yue J; Hu C; Sheng G; Zou Y
Lipids Health Dis; 2022 Oct; 21(1):95. PubMed ID: 36207744
[TBL] [Abstract][Full Text] [Related]
20. Serum butyrylcholinesterase/HDL-cholesterol ratio and atherogenic index of plasma in patients with fatty liver disease.
Turecký L; Kupčová V; Urfinová M; Repiský M; Uhlíková E
Vnitr Lek; 2021; 67(E-2):4-8. PubMed ID: 34074098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
